# From network biology to immunity: potential longitudinal biomarkers for targeting the network topology of the HIV reservoir

**Authors:** Heng-Chang Chen

PMC · DOI: 10.1186/s12967-025-06919-z · Journal of Translational Medicine · 2025-08-13

## TL;DR

This paper explores how network biology can identify biomarkers for the HIV reservoir by analyzing network topology and comparing them with experimental findings.

## Contribution

The paper introduces potential longitudinal biomarkers for the HIV reservoir derived from network-based analysis.

## Key findings

- Network topology analysis can reveal functional roles in the HIV reservoir.
- Longitudinal biomarkers from network analysis are compared with experimentally derived ones.
- Graph theory concepts are applied to understand HIV reservoir network organization.

## Abstract

In the “omics” era, studies often utilize large-scale datasets, eliciting the overall functional machinery of a network’s organization. In this context, determining how to read the enormous number of interactions in a network is imperative to comprehend its functional organization. Topology is the principal attribute of any network; as such, topological properties help to elucidate the roles of entities and represent a network’s behavior. In this review, I showcase the foundational concepts involved in graph theory, which form the basis of network biology, and exemplify the application of this conceptual framework to bridge the connection between the task-evoked functional genome network of the HIV reservoir. Furthermore, I point out potential longitudinal biomarkers identified using network-based analysis and systematically compare them with other potential biomarkers identified based on experimental research with longitudinal clinical samples.

## Full-text entities

- **Genes:** SIGLEC1 (sialic acid binding Ig like lectin 1) [NCBI Gene 6614] {aka CD169, SIGLEC-1, SN}, CD27 (CD27 molecule) [NCBI Gene 939] {aka S152, S152. LPFS2, T14, TNFRSF7, Tp55}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234] {aka CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5}, CXCL11 (C-X-C motif chemokine ligand 11) [NCBI Gene 6373] {aka H174, I-TAC, IP-9, IP9, SCYB11, SCYB9B}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic subunit 3G) [NCBI Gene 60489] {aka A3G, ARCD, ARP-9, ARP9, CEM-15, CEM15}, TBX21 (T-box transcription factor 21) [NCBI Gene 30009] {aka IMD88, T-PET, T-bet, TBET, TBLYM}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, CCL1 (C-C motif chemokine ligand 1) [NCBI Gene 6346] {aka I-309, P500, SCYA1, SISe, TCA3}, CSF1 (colony stimulating factor 1) [NCBI Gene 1435] {aka CSF-1, MCSF, PG-M-CSF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, IL1RN (interleukin 1 receptor antagonist) [NCBI Gene 3557] {aka CRMO2, DIRA, ICIL-1RA, IL-1RN, IL-1ra, IL-1ra3}, EOMES (eomesodermin) [NCBI Gene 8320] {aka TBR2}, IL7 (interleukin 7) [NCBI Gene 3574] {aka IL-7, IMD130}, CTLA4 (cytotoxic T-lymphocyte associated protein 4) [NCBI Gene 1493] {aka ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4}, PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}, TXN (thioredoxin) [NCBI Gene 7295] {aka TRDX, TRX, TRX1, TXN1, Trx80}, TNFSF10 (TNF superfamily member 10) [NCBI Gene 8743] {aka APO2L, Apo-2L, CD253, TANCR, TL2, TNLG6A}, KLRK1 (killer cell lectin like receptor K1) [NCBI Gene 22914] {aka CD314, D12S2489E, KLR, NKG2-D, NKG2D}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, SERINC5 (serine incorporator 5) [NCBI Gene 256987] {aka C5orf12, TPO1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, SERINC3 (serine incorporator 3) [NCBI Gene 10955] {aka AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1}, CD101 (CD101 molecule) [NCBI Gene 9398] {aka EWI-101, IGSF2, V7}, PML (PML nuclear body scaffold) [NCBI Gene 5371] {aka MYL, PP8675, RNF71, TRIM19}, IFI16 (interferon gamma inducible protein 16) [NCBI Gene 3428] {aka IFNGIP1, PYHIN2}, HAVCR2 (hepatitis A virus cellular receptor 2) [NCBI Gene 84868] {aka CD366, HAVcr-2, KIM-3, SPTCL, TIM3, TIMD-3}, LTA (lymphotoxin alpha) [NCBI Gene 4049] {aka LT, TNFB, TNFSF1, TNLG1E}, IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, CXCR5 (C-X-C motif chemokine receptor 5) [NCBI Gene 643] {aka BLR1, CD185, MDR15}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, SIGLEC6 (sialic acid binding Ig like lectin 6) [NCBI Gene 946] {aka CD327, CD33L, CD33L1, CD33L2, CDW327, OBBP1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}, LAMP1 (lysosome associated membrane protein 1) [NCBI Gene 3916] {aka CD107a, LAMPA, LGP120}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CD33 (CD33 molecule) [NCBI Gene 945] {aka CD33rSiglec, SIGLEC-3, SIGLEC3, p67}, CD69 (CD69 molecule) [NCBI Gene 969] {aka AIM, BL-AC/P26, CLEC2C, EA1, GP32/28, MLR-3}, IL27 (interleukin 27) [NCBI Gene 246778] {aka IL-27, IL-27A, IL27A, IL27p28, IL30, p28}, LBP (lipopolysaccharide binding protein) [NCBI Gene 3929] {aka BPIFD2}, FAS (Fas cell surface death receptor) [NCBI Gene 355] {aka ALPS1A, APO-1, APT1, CD95, FAS1, FASTM}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, PF4 (platelet factor 4) [NCBI Gene 5196] {aka CXCL4, PF-4, SCYB4}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, BST2 (bone marrow stromal cell antigen 2) [NCBI Gene 684] {aka CD317, HM1.24, TETHERIN}, IL16 (interleukin 16) [NCBI Gene 3603] {aka LCF, NIL16, PRIL16, prIL-16}, IL22 (interleukin 22) [NCBI Gene 50616] {aka IL-21, IL-22, IL-D110, IL-TIF, ILTIF, TIFIL-23}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, NEFL (neurofilament light chain) [NCBI Gene 4747] {aka CMT1F, CMT2E, CMTDIG, NF-L, NF68, NFL}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, CX3CL1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 6376] {aka ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, TRIM5 (tripartite motif containing 5) [NCBI Gene 85363] {aka RNF88, TRIM5alpha}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}
- **Diseases:** infection (MESH:D007239), HIV viremia (MESH:D014766), tuberculosis co-infection (MESH:D060085), cancer (MESH:D009369), NfL. (MESH:D020795), SIV infection (MESH:D016097), HIV (MESH:D015658), AIDS (MESH:D000163), infectious diseases (MESH:D003141), HIV Tat (MESH:D020176), B (MESH:D006509), inflammation (MESH:D007249), neurological damage (MESH:D020196)
- **Chemicals:** nucleotide (MESH:D009711), glutathione (MESH:D005978)
- **Species:** gut metagenome (species) [taxon 749906], Simian immunodeficiency virus (no rank) [taxon 11723], Qubevirus faecium (species) [taxon 39804], Human immunodeficiency virus 2 (no rank) [taxon 11709], Simian-Human immunodeficiency virus (species) [taxon 57667], Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus (species) [taxon 12721], Human immunodeficiency virus 1 (no rank) [taxon 11676], Macaca mulatta (rhesus macaque, species) [taxon 9544]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12351972/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12351972/full.md

---
Source: https://tomesphere.com/paper/PMC12351972